2cureX is accelerating the commercialization of IndiTreat® by signing two distributor agreements to prepare for launch in second half of 2020
2cureX AB (“2cureX”, NASDAQ: 2CUREX) today announces that the company has established two partnership agreements to support the commercialization of the IndiTreat® test in Europe. The partnership agreements with YourRad AB, Sweden and Paralax Life Science Group, Bulgaria will help increase the commercial activities and interactions with public and private hospitals in these markets. 2cureX will launch the IndiTreat® test in the European market in the second half of 2020.These distributor partnerships will help position IndiTreat® towards a larger customer base and will utilize our